Bexion Pharmaceuticals, Inc
Bexion Pharmaceuticals, Inc., based in Covington, KY, is a clinical-stage biopharmaceutical company focused on developing innovative biologic therapies aimed at treating solid tumors and chemotherapy-induced peripheral neuropathy (CIPN). Their lead product, BXQ-350, is designed to target metastatic colorectal cancer while potentially addressing the painful side effects of chemotherapy.
Bexion's unique approach involves modulating sphingolipid metabolism to create an anti-tumor environment and improve patient outcomes. With encouraging Phase 1 data and ongoing trials, the company aims to redefine treatment options for metastatic colorectal cancer and expand its therapeutic portfolio into additional cancer types and neuropathic pain treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.


